Corporate | 30 January 2006 14:49
ECKERT & ZIEGLER Strahlen- und Medizintechnik AG: Eckert & Ziegler Takes over Radiopharmaceutical Production for the Charité
Corporate-news transmitted by DGAP – a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
——————————————————————————
Berlin, 30.01.2006. The Berlin Charité university hospital and Eckert &
Ziegler AG (ISIN DE0005659700) will expand their existing joint efforts in
the field of nuclear medicine to also work closely together in producing
short-lived radiopharmaceutical products. The Berlin-based isotope
specialist will operate the cyclotron at the Charité site in Schumannstraße
as of February 1, forming a Berlin cyclotron association together with its
own site in the district of Adlershof. A five-year contract to this effect
was signed on last Friday by the executive officers of the Charité and the
Eckert & Ziegler subsidiary EURO-PET Berlin Zyklotron GmbH.
This agreement will save millions of euros in operating costs for the
Charité while retaining use of the facility’s products. For its part,
Eckert & Ziegler can use the facility to increase its production capacities
while gaining an expert development site for innovative radiopharmaceutical
products. To deepen cooperative efforts, the agreement also stipulates that
university staff can use the cyclotron for research purposes and that
Eckert & Ziegler will now be the exclusive supplier of a series of
innovative radiopharmaceutical products to the Charité.
‘This contract is an outstanding example of the mutual increase in
efficiency that results from cooperation between university clinics and
specialized companies,’ noted Dr. Andreas Hey, the managing director of
EURO-PET Berlin Zyklotron GmbH. ‘The Charité benefits in terms of business,
treatment, and research, while Eckert & Ziegler AG gains critical mass and
enhances this medical site as a high-powered supplier of specialty products
in the field of nuclear medicine. We are pleased with this decision by the
Charité executive board and look forward to working together with them.’
Your contact:
Eckert & Ziegler AG, Karolin Riehle, Public Relations
Robert-Rössle-Str. 10, D-13125 Berlin
phone: +49 (0) 30 / 94 10 84-138; fax: -112
e-mail: karolin.riehle@ezag.de, www.ezag.de
(c)DGAP 30.01.2006
—————————————————————————
language: English
emitter: ECKERT & ZIEGLER Strahlen- und Medizintechnik AG
Robert-Rössle-Str. 10
13125 Berlin Deutschland
phone: +49 (0)30 941 084-0
fax: +49 (0)30 941 084-112
email: karolin.riehle@ezag.de
WWW: www.ezag.de
ISIN: DE0005659700
WKN: 565970
indexes:
stockmarkets: Geregelter Markt in Frankfurt; Freiverkehr in Berlin-Bremen,
Hannover, Düsseldorf, Hamburg, Stuttgart
End of News DGAP News-Service
—————————————————————————